The endocannabinoid system and Parkinson’s disease

According to a literature review published in the journal of Neurotoxicity Research, cannabinoids, provide a potential multi-targeted treatment strategy for patients with Parkinson’s disease and dyskinesia.

Picture Source : WebMD/3D4 Medical



Related Posts

Leave a comment

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.